Neutralizing CXCL9, CXCL10, or IFN-γ reduces CXCR3-expressing activated T cells infiltrating tumors and abrogates IL-7/IL-7rα-Fc-mediated tumor growth inhibition. The gene discussed is IL7; the disease is neoplasm.